`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`NUVASIVE, INC.
`Petitioner
`
`v.
`
`WARSAW ORTHOPEDICS, INC.
`Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2013-00208
`Patent 8,251,997
`
`
`
`
`
`
`
`
`
`
`
`
`PETITIONER’S RESPONSE TO THE MOTION FOR OBSERVATION REGARDING
`CROSS-EXAMINATION OF MR. MILES
`
`
`
`Case IPR2013-00208
`Attorney Docket No: 13958-112IP1
`
`Response to the Introduction
`
`This paper responds to Patent Owner’s motion for observation regarding cross-
`
`examination of Mr. Miles, filed Apr. 22, 2014. Patent Owner states in its introductory
`
`paragraph that it filed its “observations based on Mr. Miles’ prior sworn testimony” “[i]n lieu
`
`of taking additional depositions.” However, Petitioner made Mr. Miles and Dr. Brantigan, Dr.
`
`McAfee, and Dr. Jacobson available to Patent Owner for depositions. It was Patent
`
`Owner’s choice to comment on Mr. Miles’ prior testimony and to forego a deposition in
`
`which Mr. Miles could explain that the supposed inconsistencies do not exist. Petitioner
`
`disagrees with Patent Owner’s characterization of Mr. Miles’ prior testimony as explained
`
`below.
`
`Response to Observation No. 1
`
`In Observation No. 1, Patent Owner identifies prior testimony by Mr. Miles discussing
`
`NuVasive’s CoRoent XL implant. In Exhibit 2064 at page 420, line 17 to page 421, line 9,
`
`Mr. Miles testified to the importance of the group of technologies that comprise the XLIF
`
`procedure to the safety and reproducibility of the procedure. In Exhibit 2064 at page 421,
`
`lines 8-9, Mr. Miles testified that “It is an assembled group of things that makes the thing
`
`successful.” In Exhibit 2064 at page 422:21-423:2, Mr. Miles agreed with the testimony of
`
`Dr. Smith that the CoRoent implant was innovative. In Exhibit 2064 at page 423, lines 3-7,
`
`Mr. Miles explained that “there’s many elements that make it [the CoRoent implant]
`
`innovative.” In fact, Mr. Miles never testified that the length of the CoRoent XL implant “is
`
`2
`
`
`
`Case IPR2013-00208
`Attorney Docket No: 13958-112IP1
`innovative because it spans the entire width of the vertebral body” as Patent Owner
`
`contends. Rather, Mr. Miles’ previous testimony is entirely consistent with his declaration
`
`testimony that there are many elements that make the CoRoent implant innovative,
`
`including “a patented fusion implant design that, unlike the implants disclosed in the '997
`
`patent, does not require the removal of portions of the adjacent vertebrae (see, e.g., U.S.
`
`Patent Nos. 8,187,334 and 8,361,156, Exhibits 1065 and 1066).” Ex. 1032, ¶ 9.
`
`Response to Observation No. 2
`
`In Observation No. 2, Patent Owner identifies previous testimony by Mr. Miles
`
`discussing two different procedures at Medtronic referred to by the acronym “ELIF.” In
`
`Exhibit 2064 at page 447, lines 7-10, Mr. Miles testified that in the ELIF procedure he
`
`worked on, ELIF stood for “endoscopic lumbar interbody fusion.” (Emphasis added). Mr.
`
`Miles testified at page 474, lines 20-23 that ELIF “looked nothing like a lateral approach.” In
`
`Exhibit 2064 at page 433, line 5 to page 434, line 6, Mr. Miles testified that a document he
`
`was shown referencing a procedure where the E in ELIF stood for “extreme” was dated after
`
`Mr. Miles left Medtronic. In Exhibit 2064 on page 450, lines 8-10, Mr. Miles testified that he
`
`did not copy anything from Medtronic Sofamor Danek in his work at NuVasive. This is all
`
`consistent with Mr. Miles’ declaration testimony that he did not copy the ELIF name or
`
`technology. See Ex. 1032, ¶¶ 14-16.
`
`
`
`3
`
`
`
`Case IPR2013-00208
`Attorney Docket No: 13958-112IP1
`Respectfully submitted,
`
`
` /Stephen R. Schaefer, Reg. No. 37,927/
`Stephen R. Schaefer
`Reg. No. 37,927
`
`
`
`
`
`
`
`
`
`
`
`
`
`Date: May 9, 2014
`
`
`Customer Number 26171
`Fish & Richardson P.C.
`Telephone: (612) 337-2508
`Facsimile: (612) 288-9696
`
`4
`
`
`
`Case IPR2013-00208
`Attorney Docket No: 13958-112IP1
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR §§ 42.6(e)(4) and 42.205(b), the undersigned certifies that on
`
`May 9, 2014, a complete and entire copy of this PETITIONER’S RESPONSE TO THE
`MOTION FOR OBSERVATION REGARDING CROSS-EXAMINATION OF MR. MILES was
`provided via email to the Patent Owner by serving the correspondence email addresses of
`record as follows:
`
`Thomas H. Martin
`Wesley C. Meinerding
`Martin & Ferraro, LLP
`1557 Lake O’Pines Street, NE
`Hartville, OH 44632
`
`Email: tmartin@martinferraro.com
`Email: docketing@martinferraro.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/Jessica K. Detko/
`
`Jessica K. Detko
`Fish & Richardson P.C.
`60 South Sixth Street, Suite 3200
`Minneapolis, MN 55402
`(858) 678-5667
`
`
`
`
`
`
`
`5
`
`